These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5508902)

  • 1. [Pharmacokinetics in chronic hepatopathies. Studies on an aminophenazone model].
    Wagner K; Schneider G; Leutke D; Schimmelpfennig W; Theuer D; Heinemann L
    Dtsch Gesundheitsw; 1970 Jun; 25(24):1109-14. PubMed ID: 5508902
    [No Abstract]   [Full Text] [Related]  

  • 2. [Aminophenazone half life in patients with chronic liver parenchyma disorders].
    Ackermann E; Renger F; Dökert B; Walther M
    Z Gesamte Inn Med; 1972 Oct; 27(19):849-53. PubMed ID: 4647370
    [No Abstract]   [Full Text] [Related]  

  • 3. [Significance of the liver for the biological activity of drugs].
    Ackermann E
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):3-8. PubMed ID: 5501425
    [No Abstract]   [Full Text] [Related]  

  • 4. [Azathioprine pharmacokinetics in animal experiment and in patients with chronic liver diseases].
    Bär U; Becker H; May B; Mayer D; Ohlendorf S; Otto P; Schmidt FW
    Verh Dtsch Ges Inn Med; 1973; 79():943-6. PubMed ID: 4790049
    [No Abstract]   [Full Text] [Related]  

  • 5. [Benzodiazepines and liver diseases. Pharmacokinetics and pharmacodynamic effects].
    Antoni M; Botta-Fridlund D; Bourlière M; Bun H; Gauthier AP
    Gastroenterol Clin Biol; 1990; 14(5):492-500. PubMed ID: 1973130
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmaco-metabolic activity in chronic hepatopathies: influence of treatment with UDPG].
    Okolicsànyi L; Orlando R; Lirussi F; Naccarato R; Dal Brun G
    Clin Ter; 1980 May; 93(4):431-8. PubMed ID: 6998643
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chronic right heart insufficiency and drug metabolism. Research based on aminophenazone].
    Wagner K; Koppatz K; Günther KH; Schneider G
    Dtsch Gesundheitsw; 1971 Jul; 26(28):1303-5. PubMed ID: 5096983
    [No Abstract]   [Full Text] [Related]  

  • 8. Output of 14CO2 in breath after oral administration of (14C-methyl) aminopyrine in hepatitis, cirrhosis and hepatic bilharziasis: its relationship to aminopyrine pharmacokinetics.
    Noordhoek J; Dees J; Savenije-Chapel EM; Wilson JH
    Eur J Clin Pharmacol; 1978 May; 13(3):223-9. PubMed ID: 668778
    [No Abstract]   [Full Text] [Related]  

  • 9. The determination of aminopyrin elimination for control of the metabolic capacity of the liver in man.
    Haustein KO; Hüller G; Sensing H
    Eur J Clin Invest; 1982 Apr; 12(2):157-64. PubMed ID: 6807687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on vitamin B12 resorption in chronic liver diseases].
    Konrad H; Teichmann W; Kiencke H; Bielka B; Claus R
    Dtsch Z Verdau Stoffwechselkr; 1973; 33(4):179-83. PubMed ID: 4792418
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacokinetics of thiamphenicol. Behavior in a acute and chronic hepatic insufficiency].
    Menz HP; Bezler HJ; Hartmann I; von Oldershausen HF
    Arzneimittelforschung; 1974 Jan; 24(1):99-102. PubMed ID: 4406121
    [No Abstract]   [Full Text] [Related]  

  • 12. The relationship between aminopyrine breath test and severity of liver disease in cirrhosis.
    Morelli A; Narducci F; Pelli MA; Farroni F; Vedovelli A
    Am J Gastroenterol; 1981 Aug; 76(2):110-3. PubMed ID: 6795921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prescription of drugs in liver diseases].
    Held H
    Internist (Berl); 1980 Dec; 21(12):724-34. PubMed ID: 7009474
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hydroxyproline excretion in children with chronic liver diseases].
    Zhivitsa LV; Safonova ES
    Vopr Okhr Materin Det; 1976 May; 21(5):64-7. PubMed ID: 1027285
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on bilirubin glucuronide. I. A study on the relation of bilirubin glucuronide in bile and liver damage].
    Takagi M
    Igaku Kenkyu; 1969 Jun; 39(3):255-64. PubMed ID: 5389947
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of the isotope method for studying albumin metabolism in patients with chronic liver diseases].
    Vinogradov VA; Baranenkov AI
    Ter Arkh; 1974; 46(3):118-23. PubMed ID: 4828489
    [No Abstract]   [Full Text] [Related]  

  • 17. [Behavior of lipid classes and fatty acids in different stages of alcoholic liver disease].
    Marzo A; Ghirardi P
    Recenti Prog Med; 1971 Nov; 51(5):409-19. PubMed ID: 5172395
    [No Abstract]   [Full Text] [Related]  

  • 18. [Iron metabolism and enteral iron absorption in liver diseases].
    Rommel K; Gladtke E; Mähr G; Grimmel K; Burkhardt H
    Schweiz Med Wochenschr; 1968 Nov; 98(47):1854-9. PubMed ID: 5704710
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes in thyroxine-binding capacity in liver diseases].
    Pottkämper G; Gatz J; Schwinn G; Hesch RD; Köbberling J
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():322-5. PubMed ID: 829382
    [No Abstract]   [Full Text] [Related]  

  • 20. [Transferrin anomalies in some acute and chronic liver diseases].
    Fiaschi E; Scuro LA; Dobrilla G
    Epatologia; 1969; 15(4):279-94. PubMed ID: 5407546
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.